Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINOXY: Intravenous Oxytocin for Acute Pain Sensitization in Healthy Volunteers
NCT07409753Phase 2Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in acute pain, sponsored by Wake Forest University Health Sciences. Started Oct 2025; status: recruiting.
02
Drugs
oxytocin
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07409753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07409753.